Advances in the epigenetics of fibroblast biology and fibrotic diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in the epigenetics of fibroblast biology and fibrotic diseases

Published:2019-12 Issue: Volume:49 Page:102-109
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Ulukan Bürge,Sila Ozkaya Yasemin,Zeybel Müjdat

Funder

Scientific and Technological Research Council of Turkey

Newton-Katip Çelebi Fund

Republic of Turkey Ministry of Development

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference48 articles.

1. Fibrosis: ultimate and proximate causes;Thannickal;J Clin Invest,2014

2. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study;Allen;Lancet Respir Med,2017

3. Genetic architecture of human fibrotic diseases: disease risk and disease progression;Gardet;Front Pharmacol,2013

4. Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity;Angermueller;Nat Methods,2016

5. DNA methylation detection: recent developments in bisulfite free electrochemical and optical approaches;Bhattacharjee;Analyst,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A point-of-research decision in synovial tissue engineering: Mesenchymal stromal cells, tissue derived fibroblast or CTGF-mediated mesenchymal-to-fibroblast transition;European Journal of Cell Biology;2024-09

2. The landscape of histone modification in organ fibrosis;European Journal of Pharmacology;2024-08

3. Nanocarrier-Mediated Delivery of MicroRNAs for Fibrotic Diseases;Molecular Diagnosis & Therapy;2023-10-28

4. EHMT2/G9a-Inhibition Reprograms Cancer-Associated Fibroblasts (CAFs) to a More Differentiated, Less Proliferative and Invasive State;2023-07-18

5. Long non-coding RNAs: key regulators of liver and kidney fibrogenesis;BMB Reports;2023-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3